Corporate Social Responsibility
Corporate Social Responsibility (CSR)
Genmab’s commitment to Corporate Social Responsibility (CSR) is anchored in our company’s core purpose “to improve the lives of patients by creating and developing innovative antibody products” and our vision “By 2025 our own product has transformed cancer treatment and we have a pipeline of knock-your-socks-off antibodies.”
Our vision inspires and motivates us to create differentiated antibody products that have the potential to provide new treatment options to patients with life-threatening and debilitating diseases. We believe we have a responsibility to ensure our actions benefit our direct stakeholders (patients, shareholders and employees) and society as a whole. With our core values and vision in mind, being socially responsible is fundamental to the way we do business at Genmab.
In conducting our business, Genmab complies with all relevant laws, standards and guidelines. We also consider the well-being of our employees a top priority, and we minimize our impact on the environment to the extent possible. We have high ethical standards and aim to conduct business with companies and within countries that share our ethics and respect the protection of internationally proclaimed human rights. As we conduct business in a highly regulated industry, we have chosen not to implement a specific human rights policy. It is important to us however, to support and respect the protection of internationally proclaimed human rights through other policies that address responsible supply chain management, ethical procedures, health and safety procedures, anti-bribery and anti-corruption policies and issues regarding access to medicine. Genmab strives to only conduct clinical trials in markets where a drug is planned to become available. Furthermore, Genmab does not employ child labor.
Our CSR Committee, chaired by a member of our Executive Management Team, is comprised of representatives from our human resources, investor relations and communications, legal, compliance, finance and research and development functions. The committee ensures that Genmab carries out its CSR activities effectively and communicates them clearly and openly.
Genmab publishes its statutory report on CSR for the financial year 2019 cf. Section 99 a of the Danish Financial Statements Act on the company’s website, including additional information about policies, progress made during 2019 and expected activities for 2020. Genmab’s CSR report discloses the main highlights of our CSR initiatives but does not reflect all our ongoing initiatives and procedures. We also monitor new developments and practices and consider implementing new initiatives that could further enhance our CSR activities when appropriate.
Click the link below to access Genmab’s statutory report on CSR for the financial year 2019 cf. Section 99a of the Danish Financial Statements Act (“Lovpligtig redegørelse for samfundsansvar, jf. årsregnskabslovens § 99 a”), including additional information about policies, progress made during 2019 and expected activities for 2020.
CSR Report 2019 - English
Policy regarding the Diversity and Proportion of Gender in other Management Levels of the Genmab group:
This policy has been adopted by the Board of Directors of Genmab A/S ("Genmab") in accordance with Section 139a of the Danish Companies Act and the Danish Recommendations on Corporate Governance.
Genmab recognizes the importance of promoting diversity and is committed to continue working towards and maintaining diversity and equal opportunities for employees at all management levels in the Genmab group, regardless of gender, age, race, religion or ethnicity. Genmab encourages talented employees to pursue a career in the company. Genmab regularly conducts employee surveys and employee development interviews to identify barriers – or the perception of barriers – preventing equal opportunities for employees. In connection with recruitment, including recruitment at management level, it is the policy of the Genmab group to meet the company's needs for employees with the right skills and competences, regardless of gender, age, race, religion or ethnicity. When choosing between equally qualified candidates, the diversity among the employees shall be taken into consideration, as it is the aim that both genders attain a representation at management levels of at least 40%. In connection with recruitment for managerial positions it must be ensured that the employment procedures are designed to give men and women equal opportunities to apply for and obtain managerial positions and, where possible, that the candidates invited for interview include both men and women. The company's focus on diversity among its employees, including at management levels, must be visible during recruitment.
The policy may be amended by the Board of Directors and should be interpreted in accordance with applicable equal rights and anti-discrimination legislation in Denmark, in force from time to time.
A Target Figure for the Number of Women in the Board of Directors of Genmab A/S has been established. Click here for more information.